Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis (BMC Neurology)

Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events includ...